Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance
暂无分享,去创建一个
[1] J. Hirsh,et al. A standard heparin nomogram for the management of heparin therapy. , 1991, Archives of internal medicine.
[2] J. Hirsh,et al. Contribution of Red Blood Cells to the Saturable Mechanism of Heparin Clearance , 1990, Thrombosis and Haemostasis.
[3] L. Leung,et al. Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes. Effects of histidine-rich glycoprotein. , 1989, Blood.
[4] B. Boneu,et al. Pharmacokinetic Studies of Standard Unfractionated Heparin, and Low Molecular Weight Heparins in the Rabbit , 1988, Seminars in thrombosis and hemostasis.
[5] G. Tobelem,et al. Selective binding of heparins to human endothelial cells. Implications for pharmacokinetics. , 1987, Thrombosis research.
[6] G. Raskob,et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. , 1986, The New England journal of medicine.
[7] M. Petitou,et al. Endothelial binding sites for heparin. Specificity and role in heparin neutralization. , 1986, The Biochemical journal.
[8] G. Torri,et al. Retention of antilipemic activity by periodate-oxidized non-anticoagulant heparins. , 1986, Arzneimittel-Forschung.
[9] J. Hirsh. Mechanism of Action and Monitoring of Anticoagulants , 1986, Seminars in thrombosis and hemostasis.
[10] I. Talstad. Heparin therapy adjusted for body weight. , 1985, American journal of clinical pathology.
[11] M. Harris,et al. The effect of platelet factor 4 (PF4) on assays of plasma heparin , 1984, British journal of haematology.
[12] M. Hoylaerts,et al. Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma. , 1983, The Journal of biological chemistry.
[13] M. Lie,et al. Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III. , 1977, Thrombosis research.
[14] J. Hirsh,et al. Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis. , 1977, Blood.
[15] C. Dollery,et al. Heparin Kinetics in Venous Thrombosis and Pulmonary Embolism , 1976, Circulation.
[16] J. Hirsh,et al. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. , 1972, The New England journal of medicine.
[17] J. White,et al. Kaolin partial thromboplastin time: high levels of procoagulants producing short clotting times or masking deficiencies of other procoagulants or low concentrations of anticoagulants. , 1967, The Journal of laboratory and clinical medicine.